cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Becton Dickinson And Company
66 own
14 watching
Current Price
$250.23
$-2.96
(-1.17%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
91,243.84M
52-Week High
52-Week High
277.29
52-Week Low
52-Week Low
215.9
Average Volume
Average Volume
1.07M
Dividend Yield
Dividend Yield
0.013623
P/E Ratio
P/E Ratio
37.5288
iconMarket Capitalization91,243.84M
icon52-Week High277.29
icon52-Week Low215.9
iconAverage Volume1.07M
iconDividend Yield0.013623
iconP/E Ratio37.5288
What does the Becton Dickinson And Company do?
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women's health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Read More
How much money does Becton Dickinson And Company make?
News & Events about Becton Dickinson And Company.
PR Newswire
6days ago
BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery PR Newswire FRANKLIN LAKES, N.J., Feb. 3, 2023 New BD Rhapsody HT Xpress System and Other...
Zolmax
25days ago
Great West Life Assurance Co. Can bought a new position in shares of Becton, Dickinson and Company (NYSE:BDX Get Rating) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 225,831 shares of the medical instruments suppliers stock, ...
Ticker Report
1month ago
Becton, Dickinson and (NYSE:BDX Get Rating) had its price target boosted by stock analysts at Morgan Stanley from $275.00 to $290.00 in a report released on Friday, Benzinga reports. The brokerage presently has an overweight rating on the medical instruments suppliers ...
PR Newswire
1month ago
Michelle Quinn Named Acting General Counsel for BD Michelle Quinn Named Acting General Counsel for BD PR Newswire FRANKLIN LAKES, N.J., Jan. 6, 2023 FRANKLIN LAKES, N.J., Jan. 6, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company...
Ticker Report
1month ago
Shares of Becton, Dickinson and Company (NYSE:BDX Get Rating) have been assigned an average recommendation of Hold from the thirteen analysts that are covering the company, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and four have ...
Frequently Asked Questions
Frequently Asked Questions
What is Becton Dickinson And Company share price today?
plus_minus_icon
Can Indians buy Becton Dickinson And Company shares?
plus_minus_icon
How can I buy Becton Dickinson And Company shares from India?
plus_minus_icon
Can Fractional shares of Becton Dickinson And Company be purchased?
plus_minus_icon
What are the documents required to start investing in Becton Dickinson And Company stocks?
plus_minus_icon
What is today’s traded volume of Becton Dickinson And Company?
plus_minus_icon
What is today’s market capitalisation of Becton Dickinson And Company?
plus_minus_icon
What is the 52-Week High and Low Range of Becton Dickinson And Company?
plus_minus_icon
What percentage is Becton Dickinson And Company down from its 52-Week High?
plus_minus_icon
What percentage is Becton Dickinson And Company up from its 52-Week Low?
plus_minus_icon
Current Price
$250.23
$-2.96
(-1.17%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00